Patients with moderate-to-severe obstructive sleep apnea (OSA) and obesity who undergo bariatric surgery have significantly reduced risks of major adverse cardiovascular events and all-cause mortality ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Metabolic surgery became the first therapy associated with a ...

Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...

A million things could make you feel tired 24/7, but this underdiagnosed condition could be to blame.

The obesity and diabetes medication tirzepatide (Mounjaro, Zepbound) reduced obstructive sleep apnea events by as much as two-thirds in new clinical trials. The abstract (but not the complete study) ...

Study expands the backing for sleep apnea-specific hypoxic burden ...

The current study was a meta-analysis of 18 large, prospective, randomized, controlled studies with a total of 4146 patients. The included studies had "cardiovascular," "mortality," or "blood pressure ...

Women over 50 are being diagnosed with sleep apnea at record rates — not because of a sudden epidemic, but because medicine ...

Women over 50 with sleep apnea rarely snore loudly or fit the textbook profile. Instead, they show up with anxiety, brain fog ...

CHICAGO -- An investigational proximal hypoglossal nerve stimulation device helped control obstructive sleep apnea (OSA), the OSPREY randomized trial showed. The Apnea-Hypopnea Index (AHI) response ...